Veraxa Biotech AG - Post de-SPAC VRXA
NASDAQ VRXA
$1.15 -0.04 (-3.36%)
As of: Oct 2, 2026 · 9:38 AM EDT

Veraxa Biotech AG - Post de-SPAC (VRXA) Debt Ratio (2025)

Updated

Veraxa Biotech AG - Post de-SPAC's (VRXA) Debt Ratio came in at 0.01 for the quarter ended Dec 31, 2025.

Analysis

Veraxa Biotech AG - Post de-SPAC (VRXA) Debt Ratio (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 0.24
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 0.52
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 0.42
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 0.31
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 0.00
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 0.60
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 0.53
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Veraxa Biotech AG - Post de-SPAC 18.09 Mn 14.68 Mn - 0.01
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 0.01
API Access

Veraxa Biotech AG - Post de-SPAC Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=VRXA&period=max&api_key=YOUR_API_KEY